(Q30359158)

16 August 2017

Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs (English)

1 reference

16 August 2017

1 reference

1 reference

Vishal Ahuja

1

1 reference

16 August 2017

Min-Woong Sohn

2

1 reference

16 August 2017

John R Birge

3

1 reference

16 August 2017

Chad Syverson

4

1 reference

16 August 2017

Elly Budiman-Mak

5

1 reference

16 August 2017

Nicholas Emanuele

6

1 reference

16 August 2017

Jennifer M Cooper

7

1 reference

16 August 2017

Elbert S Huang

8

1 reference

16 August 2017

1 December 2015

1 reference

Journal of Managed Care & Specialty Pharmacy

16 August 2017

1 reference

16 August 2017

21

1 reference

16 August 2017

12

1 reference

16 August 2017

1214-1234

1 reference

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Medication adherence: WHO cares?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Clinical consequences of disseminating the rosiglitazone FDA safety warning.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Changes in glitazone use among office-based physicians in the U.S., 2003-2009.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: the REasons for Geographic And Racial Differences in Stroke Study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

From best evidence to best practice: effective implementation of change in patients' care

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Geographic variation in health care utilization and outcomes in veterans with acute myocardial infarction

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Department of Veterans Affairs' Quality Enhancement Research Initiative for Diabetes Mellitus

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Geographic variations in utilization rates in Veterans Affairs hospitals and clinics

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Geographic variation in medication adherence in commercial and Medicare part D populations.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

FDA warning and removal of rosiglitazone from VA national formulary.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Use of rosiglitazone and pioglitazone immediately after the cardiovascular risk warnings.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Responding to an FDA warning--geographic variation in the use of rosiglitazone

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Effect of increased copayments on pharmacy use in the Department of Veterans Affairs

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4861222

Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26679970

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Geographic variation of spirometry use in newly diagnosed COPD

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26679970

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

FDA drug prescribing warnings: is the black box half empty or half full?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26679970

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18553/JMCP.2015.21.12.1214

0 references

1 reference

16 August 2017

PubMed publication ID

26679970

1 reference